alprazolam has been researched along with Absence Seizure in 24 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Excerpt | Relevance | Reference |
---|---|---|
"This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule." | 7.68 | Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990) |
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam." | 7.67 | Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984) |
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks." | 7.67 | Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986) |
" Reported here is the occurrence of myoclonic seizures after the abrupt discontinuation of phenelzine and alprazolam." | 7.67 | Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam. ( Cameron, O; Grunhaus, L; Naylor, MW, 1987) |
"0 mg doses of Staccato alprazolam demonstrated efficacy in rapidly terminating seizures in an inpatient setting and were well tolerated." | 5.69 | A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination. ( Biton, V; Dave, H; Detyniecki, K; DiVentura, B; French, J; Gelfand, MA; Gong, H; Isojarvi, J; Liow, K; O'Brien, TJ; Reich, B; Sadek, A, 2023) |
"alprazolam and ketamine, was tested in two types of seizure activity." | 5.30 | Effect of alprazolam and ketamine on seizures induced by two different convulsants. ( Herink, J, 1997) |
"We evaluated racemic zopiclone, its (S)- and (R)-enantiomers and a metabolite, (S)-desmethylzopiclone, for their actions on locomotor activity, rotarod performance, the elevated plus maze and the Vogel conflict test of anxiety, and electroconvulsive shock-induced seizures duration." | 3.71 | Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite. ( Carlson, JN; Glick, SD; Haskew, R; Jerussi, TP; Maisonneuve, IM; Wacker, J, 2001) |
"This is a case report of severe psychosis and seizures following abrupt discontinuation of alprazolam and then the recurrence of seizures at the end of a gradual tapering schedule." | 3.68 | Death following suspected alprazolam withdrawal seizures: a case report. ( Bryant, SG; Haque, W; Watson, DJ, 1990) |
"A case is reported of delirium and seizures due to the abrupt withdrawal from the benzodiazepine alprazolam." | 3.67 | Delirium and seizures due to abrupt alprazolam withdrawal: case report. ( Levy, AB, 1984) |
"Seizures were observed following the withdrawal of alprazolam administered in therapeutic dose for 10 weeks." | 3.67 | Seizures following the withdrawal of alprazolam. ( Clancy, J; Coryell, WH; Crowe, RR; Gabel, J; Noyes, R; Perry, PJ; Yamada, T, 1986) |
" Reported here is the occurrence of myoclonic seizures after the abrupt discontinuation of phenelzine and alprazolam." | 3.67 | Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam. ( Cameron, O; Grunhaus, L; Naylor, MW, 1987) |
" The majority (67%) of patients interviewed discontinued alprazolam for a period of at least 3 days after a gradual dosage reduction schedule over a 4-week period at the end of the long-term treatment study." | 2.67 | Discontinuation of alprazolam after long-term treatment of panic-related disorders. ( Ballenger, JC; Burrows, GD; DuPont, RL; Noyes, R; Pecknold, JC; Rifkin, A; Rubin, RT; Swinson, RP, 1992) |
"Oxazepam is an anxiolytic with established clinical efficacy." | 2.38 | Oxazepam: update 1989. ( Ayd, FJ, 1990) |
"alprazolam and ketamine, was tested in two types of seizure activity." | 1.30 | Effect of alprazolam and ketamine on seizures induced by two different convulsants. ( Herink, J, 1997) |
"Pentylenetetrazole-induced seizure thresholds were similar in mice treated for 14 days with lorazepam or alprazolam, 2 mg/kg/day." | 1.29 | Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam. ( Byrnes, JJ; Greenblatt, DJ; Miller, LG; Shader, RI, 1993) |
"Treatment with carbamazepine attenuated (P less than 0." | 1.28 | Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine. ( Browne, TR; Galpern, WR; Greenblatt, DJ; Miller, LG; Shader, RI; Szabo, GK, 1991) |
"All had withdrawal symptoms, six demonstrated tolerance, and at least four had substantial social or occupational impairment secondary to drug use." | 1.27 | Alprazolam dependence in seven patients. ( Juergens, SM; Morse, RM, 1988) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 8 (33.33) | 18.7374 |
1990's | 12 (50.00) | 18.2507 |
2000's | 3 (12.50) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (4.17) | 2.80 |
Authors | Studies |
---|---|
Gall, M | 1 |
Lahti, RA | 1 |
Rudzik, AD | 1 |
Duchamp, DJ | 1 |
Chidester, C | 1 |
Scahill, T | 1 |
French, J | 1 |
Biton, V | 1 |
Dave, H | 1 |
Detyniecki, K | 1 |
Gelfand, MA | 1 |
Gong, H | 1 |
Liow, K | 1 |
O'Brien, TJ | 1 |
Sadek, A | 1 |
DiVentura, B | 1 |
Reich, B | 1 |
Isojarvi, J | 1 |
Mena Martín, FJ | 1 |
Dueñas Laita, A | 1 |
Pérez Castrillón, JL | 1 |
Martín Escudero, JC | 1 |
Levy, AB | 1 |
Rudorfer, MV | 1 |
Golden, RN | 2 |
Potter, WZ | 1 |
Byrnes, JJ | 1 |
Miller, LG | 2 |
Greenblatt, DJ | 2 |
Shader, RI | 2 |
Cannizzaro, C | 1 |
Cannizzaro, E | 1 |
Gagliano, M | 1 |
Mangiapane, N | 1 |
Freeman, S | 1 |
Herink, J | 2 |
Jenck, F | 1 |
Wichmann, J | 1 |
Dautzenberg, FM | 1 |
Moreau, JL | 1 |
Ouagazzal, AM | 1 |
Martin, JR | 1 |
Lundstrom, K | 1 |
Cesura, AM | 1 |
Poli, SM | 1 |
Roever, S | 1 |
Kolczewski, S | 1 |
Adam, G | 1 |
Kilpatrick, G | 1 |
Carlson, JN | 1 |
Haskew, R | 1 |
Wacker, J | 1 |
Maisonneuve, IM | 1 |
Glick, SD | 1 |
Jerussi, TP | 1 |
DuPont, RL | 1 |
Swinson, RP | 1 |
Ballenger, JC | 1 |
Burrows, GD | 1 |
Noyes, R | 2 |
Rubin, RT | 1 |
Rifkin, A | 1 |
Pecknold, JC | 1 |
Galpern, WR | 1 |
Szabo, GK | 1 |
Browne, TR | 1 |
Koupilová, M | 1 |
Hrdina, V | 1 |
Sloan, JW | 1 |
Martin, WR | 1 |
Wala, EP | 1 |
Ayd, FJ | 1 |
Entman, ML | 1 |
Haque, W | 1 |
Watson, DJ | 1 |
Bryant, SG | 1 |
Warner, MD | 1 |
Peabody, CA | 1 |
Boutros, NN | 1 |
Whiteford, HA | 1 |
Perry, PJ | 1 |
Crowe, RR | 1 |
Coryell, WH | 1 |
Clancy, J | 1 |
Yamada, T | 1 |
Gabel, J | 1 |
Brown, TM | 1 |
Miller, H | 1 |
Evans, DL | 1 |
Juergens, SM | 1 |
Morse, RM | 1 |
Patterson, WM | 1 |
Naylor, MW | 1 |
Grunhaus, L | 1 |
Cameron, O | 1 |
3 reviews available for alprazolam and Absence Seizure
Article | Year |
---|---|
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trial | 1984 |
Oxazepam: update 1989.
Topics: Aged; Alcoholism; Alprazolam; Female; Humans; Oxazepam; Seizures; Substance Withdrawal Syndrome; Sub | 1990 |
The new antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Fluoxetine; Maprotiline; Nomifensine; Seizures; Trazod | 1988 |
3 trials available for alprazolam and Absence Seizure
Article | Year |
---|---|
A randomized phase 2b efficacy study in patients with seizure episodes with a predictable pattern using Staccato® alprazolam for rapid seizure termination.
Topics: Adult; Alprazolam; Anticonvulsants; Double-Blind Method; Epilepsy; Humans; Seizures; Treatment Outco | 2023 |
Second-generation antidepressants.
Topics: Alprazolam; Amoxapine; Antidepressive Agents; Benzodiazepines; Bupropion; Citalopram; Clinical Trial | 1984 |
Discontinuation of alprazolam after long-term treatment of panic-related disorders.
Topics: Adult; Alprazolam; Double-Blind Method; Drug Administration Schedule; Drug Tolerance; Female; Follow | 1992 |
19 other studies available for alprazolam and Absence Seizure
Article | Year |
---|---|
Novel anxiolytic agents derived from alpha-amino-alpha-phenyl-o-tolyl-4H-triazoles and -imidazoles.
Topics: Animals; Anti-Anxiety Agents; Anticonvulsants; Brain; Crystallography; Hypnotics and Sedatives; Imid | 1978 |
[Seizures as late manifestation of alprazolam withdrawal syndrome].
Topics: Alprazolam; Anti-Anxiety Agents; Humans; Male; Middle Aged; Seizures; Substance Withdrawal Syndrome; | 2002 |
Delirium and seizures due to abrupt alprazolam withdrawal: case report.
Topics: Aged; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Delirium; Half-Life; Huma | 1984 |
Chronic benzodiazepine administration. XII. Anticonvulsant cross-tolerance but distinct neurochemical effects of alprazolam and lorazepam.
Topics: Alprazolam; Animals; Anticonvulsants; Brain Chemistry; Cerebral Cortex; Down-Regulation; Drug Tolera | 1993 |
Behavioural responsiveness to picrotoxin and desipramine in adult rats prenatally exposed to different benzodiazepine receptor agonists.
Topics: Adrenergic Uptake Inhibitors; Alprazolam; Animals; Behavior, Animal; Desipramine; Diazepam; Female; | 1995 |
The realities of clonazepam discontinuation.
Topics: Alprazolam; Anxiety Disorders; Benzodiazepines; Clonazepam; Drug Administration Schedule; GABA Modul | 1997 |
Effect of alprazolam and ketamine on seizures induced by two different convulsants.
Topics: Alprazolam; Animals; Anticonvulsants; Aziridines; Convulsants; Ketamine; Male; Pentylenetetrazole; R | 1997 |
A synthetic agonist at the orphanin FQ/nociceptin receptor ORL1: anxiolytic profile in the rat.
Topics: Acoustic Stimulation; Alprazolam; Animals; Anti-Anxiety Agents; Cognition; Conflict, Psychological; | 2000 |
Sedative and anxiolytic effects of zopiclone's enantiomers and metabolite.
Topics: Alprazolam; Animals; Anti-Anxiety Agents; Anticonvulsants; Anxiety; Azabicyclo Compounds; Diazepam; | 2001 |
Chronic benzodiazepine administration. IX. Attenuation of alprazolam discontinuation effects by carbamazepine.
Topics: Alprazolam; Animals; Anxiety; Carbamazepine; Cerebral Cortex; Disease Models, Animal; Drug Administr | 1991 |
Effect of alprazolam on pentylenetetrazol convulsions.
Topics: Alprazolam; Animals; Male; Pentylenetetrazole; Rats; Rats, Inbred Strains; Seizures | 1990 |
Dependence-producing properties of alprazolam in the dog.
Topics: Administration, Oral; Alprazolam; Animals; Dogs; Dose-Response Relationship, Drug; Female; Flumazeni | 1990 |
Alprazolam withdrawal.
Topics: Alprazolam; Coronary Disease; Female; Humans; Metoprolol; Seizures; Substance Withdrawal Syndrome | 1990 |
Death following suspected alprazolam withdrawal seizures: a case report.
Topics: Alprazolam; Arrhythmias, Cardiac; Death, Sudden; Female; Humans; Middle Aged; Psychoses, Substance-I | 1990 |
Alprazolam and withdrawal seizures.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alprazolam; Female; Humans; Male; Middle Aged; Seizures; | 1990 |
Seizures following the withdrawal of alprazolam.
Topics: Adult; Alprazolam; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Female; Humans; Panic; S | 1986 |
Alprazolam dependence in seven patients.
Topics: Adult; Alcoholism; Alprazolam; Anxiety Disorders; Depressive Disorder; Female; Humans; Male; Marijua | 1988 |
Triazolam withdrawal.
Topics: Alprazolam; Diazepam; Drug Tolerance; Humans; Seizures; Substance Withdrawal Syndrome; Triazolam | 1988 |
Myoclonic seizures after abrupt withdrawal from phenelzine and alprazolam.
Topics: Adult; Alprazolam; Drug Therapy, Combination; Female; Humans; Myoclonus; Phenelzine; Psychotic Disor | 1987 |